Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Janux Therapeutics Reports Breakthrough in Prostate Cancer Treatment with JANX007
NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for…
Gelteq Limited (NASDAQ: GELS): Transforming Nutraceuticals with Gel-Based Innovation and Strategic…
The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer…
Senti Biosciences, Inc. (SNTI) could keep surging and here’s why
Finance
Singular Genomics (OMIC) Surges Over 65% Following recent Acquisition Proposal from…
Monte Rosa Therapeutics Soars on Novartis Deal: A Molecular Glue Revolution
Betforward: A Gateway to Sports Betting and Online Gaming
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Citius Pharmaceuticals Inc. (NASDAQ:CTXR)
Tag: Citius Pharmaceuticals Inc. (NASDAQ:CTXR)
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Receives Study May Proceed Letter from...
Kate Hudson
-
March 1, 2022
0
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Finalizes Patient Enrolment In Pivotal Phase...
Gavins Felicity
-
December 29, 2021
0
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Completes Patients Recruitment In Phase 3...
Kate Hudson
-
December 13, 2021
0
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Reports Study Results Showing Effectiveness of Mino-Lok...
Ash K
-
December 21, 2020
0
Citius Pharmaceuticals (NASDAQ:CTXR) And Novellus Therapeutics Enter Exclusive Global Licensing Agreement...
Gavins Felicity
-
October 15, 2020
0
1
2
Page 1 of 2
Recent Post
Janux Therapeutics Reports Breakthrough in Prostate Cancer Treatment with JANX007
Gavins Felicity
-
December 3, 2024
0
In a significant development from San Diego, Janux Therapeutics, Inc. (NASDAQ: JANX) has released an update on its groundbreaking JANX007 clinical program,...
NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for...
December 3, 2024
Gelteq Limited (NASDAQ: GELS): Transforming Nutraceuticals with Gel-Based Innovation and Strategic...
December 3, 2024
The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer...
December 2, 2024
Senti Biosciences, Inc. (SNTI) could keep surging and here’s why
December 2, 2024
romabet
mahbet
پین باهیس
bettingmagazine.org
بت کارت
یاس بت
yekbet
megapari
onjabet
alvinbet
betboro
betfa
بت فوروارد
1xbet
1win
betwinner
4shart.com
1xbetgiris.cam
وان کیک بت
وین بت
ریتزوبت
1xbet-ir.com.co
وان ایکس بت
بت فوروارد